Japanese government Dec 28, 2020 Japanese Regulators Approve Lynparza for Ovarian, Prostate, Pancreatic Cancers Aug 25, 2020 FDA Accepts EMD Serono's Tepotinib Application for METex14 Advanced NSCLC Mar 25, 2020 Daiichi Sankyo's Enhertu Approved for Advanced HER2-Positive Breast Cancer in Japan Jan 2, 2020 Japanese Regulator Approves Foundation Medicine CDx for Roche's Rozlytrek in Lung Cancer Nov 21, 2019 Myriad Genetics BRACAnalysis Approved by Japanese Regulators Nov 6, 2019 Merck, Promega Collaborate to Develop MSI CDx for Keytruda Jul 3, 2019 Japan, China Launch Basket, Umbrella Trials to Expand Precision Oncology Treatment Access Premium Jun 19, 2019 Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug Jun 18, 2019 Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication Breaking News NCCN Adds Mirati Therapeutics' Krazati to Guidelines for KRAS-Mutant NSCLC With Brain Metastases European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer Genialis Closes $13M Series A Funding Round Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers
